Skip to main content
SpringerLink
Log in

Wann ambulant, wann stationär behandeln?

Letalität der ambulant erworbenen Pneumonie nicht unterschätzen!

State of the art in diagnosis and therapy of community aquired pneumonia

  • FORTBILDUNG . SCHWERPUNKT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Die ambulant erworbene Pneumonie geht vor allem bei intensivmedizinischer Behandlungsnotwendigkeit mit einer hohen Letalität einher. Risikoscores helfen bei der Schweregradabschätzung und ermöglichen Ihnen, die richtige Therapieentscheidung zu treffen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Ewig S, Höffken G, Kern WV et al. Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention — Update 2016. Pneumologie (Stuttgart, Germany) 2016; 70(3): 151–200

    Article  CAS  Google Scholar 

  2. Ewig S, Birkner N, Strauss R et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009; 64(12): 1062–1069

    Article  CAS  Google Scholar 

  3. Cilloniz C, Ferrer M, Liapikou A et al. Acute respiratory distress syndrome in mechanically ventilated patients with communityacquired pneumonia. The European respiratory journal 2018; 51(3)

    Google Scholar 

  4. Ieven M, Coenen S, Loens K et al. Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries. Clinical microbiology and infection the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018; 24(11): 1158–1163

    Article  CAS  Google Scholar 

  5. Ramirez JA, Wiemken TL, Peyrani P et al. Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality. Clinical infectious diseases an official publication of the Infectious Diseases Society of America 2017; 65(11): 1806–1812

    Article  Google Scholar 

  6. Braeken DCW, Franssen FME, Baum H von et al. Bacterial aetiology and mortality in COPD patients with CAP: results from the German Competence Network, CAPNETZ. int j tuberc lung dis 2017; 21(2): 236–243

    Article  CAS  Google Scholar 

  7. McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nature reviews. Microbiology 2014; 12(4): 252–262

    PubMed  CAS  Google Scholar 

  8. Alimi Y, Lim WS, Lansbury L et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. Journal of clinical virology the official publication of the Pan American Society for Clinical Virology 2017; 95: 26–35

    Article  CAS  Google Scholar 

  9. Bewick T, Greenwood S, Lim WS. The impact of an early chest radiograph on outcome in patients hospitalised with community-acquired pneumonia. Clinical Medicine 2010; 10(6): 563–567

    Article  Google Scholar 

  10. Reissig A, Copetti R, Mathis G et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest 2012; 142(4): 965–972

    Article  Google Scholar 

  11. Bauer TT, Ewig S, Marre R et al. CRB-65 predicts death from community-acquired pneumonia. Journal of internal medicine 2006; 260(1): 93–101

    Article  CAS  Google Scholar 

  12. Ewig S, Bauer T, Richter K et al. Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups. The European respiratory journal 2013; 41(4): 917–922

    Article  Google Scholar 

  13. Kolditz M, Ewig S, Schütte H et al. Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. Journal of internal medicine 2015; 278(2): 193–202

    Article  CAS  Google Scholar 

  14. Zhou H, Lan T, Guo S. Stratified and prognostic value of admission lactate and severity scores in patients with community-acquired pneumonia in emergency department: A single-center retrospective cohort study. Medicine 2019; 98(41): e17479

    Article  CAS  Google Scholar 

  15. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive care medicine 2018; 44(6): 925–928

    Article  CAS  Google Scholar 

  16. Pletz MWR, McGee L, Burkhardt O et al. Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy. European journal of clinical microbiology & infectious diseases official publication of the European Society of Clinical Microbiology 2005; 24(1): 58–60

    Article  CAS  Google Scholar 

  17. Rosón B, Carratalà J, Verdaguer R et al. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clinical infectious diseases an official publication of the Infectious Diseases Society of America 2000; 31(4): 869–874

    Article  Google Scholar 

  18. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67(1): 71–79

    Article  CAS  Google Scholar 

  19. Garin N, Genné D, Carballo S et al. ß-Lactam monotherapy vs ß-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA internal medicine 2014; 174(12): 1894–1901

    Article  CAS  Google Scholar 

  20. Ceccato A, Cilloniz C, Martin-Loeches I et al. Effect of Combined ß-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia. Chest 2019; 155(4): 795–804

    Article  Google Scholar 

  21. Louie JK, Yang S, Acosta M et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clinical infectious diseases an official publication of the Infectious Diseases Society of America 2012; 55(9): 1198–1204

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik I, Schwerpunkt Pneumologie / Allergologie, Universitätsklinikum Frankfurt , Theodor-Stern-Kai 7, D-60590, Frankfurt/M., Deutschland

    Achim Grünewaldt,  Christian Hügel,  Carla Bellinghausen &  Gernot Rohde

Authors
  1. Achim Grünewaldt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Hügel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carla Bellinghausen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gernot Rohde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Achim Grünewaldt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grünewaldt, A., Hügel, C., Bellinghausen, C. et al. Letalität der ambulant erworbenen Pneumonie nicht unterschätzen!. MMW - Fortschritte der Medizin 162, 39–42 (2020). https://doi.org/10.1007/s15006-020-0216-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-020-0216-2

Keywords

Search

Navigation